Skip to main content

Table 2 Specific criteria for assessment of endoscopic efficacy parameters and scoring system

From: The evaluation of three treatment protocols using oral prednisone and oral meloxicam for therapy of canine idiopathic lymphoplasmacytic rhinitis: a pilot study

Parameter

Description

Score

Final overall score of endoscopic changes

Mucous accumulation

Absent

0

0–2 (−) absent

3–5 (+) mild

6–9 (++) moderate

9 (+++) severe

Serous/ sero-mucous, small amount- mild

1

Mucous/ sero- purulent, small amount- moderate

2

Purulent/ muco-purulent/ haemorrhagic, large amount- severe

3

Severity of hyperaemia

Absent/ normal mucosa

0

Mild (present in less than 20% of nasal cavity)

1

Moderate (20–40% of nasal cavity)

2

Severe (> 40% of nasal cavity)

3

Turbinate oedema

Absent/normal mucosa

0

Oedematous mucosa

1

Marked oedema

2

Polypoid mucosa

3